Lv11
20 积分 2021-07-02 加入
Updates in systemic therapy for refractory thyroid carcinoma - targeted agents, immunotherapy, and chemotherapy
8小时前
已完结
Prognostic Indicators of Outcomes in Patients with Distant Metastases from Differentiated Thyroid Carcinoma
1个月前
已完结
Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center
1个月前
已完结
Molecular Landscape and Advanced Diagnostic Technologies for BRAF Mutations in Cancer: From Quantitative PCR and ddPCR to CRISPR-Based Platforms
1个月前
已关闭
Association of common genetic alterations with tumor recurrence in papillary thyroid cancer
1个月前
已完结
Selpercatinib-induced Redifferentiation and Enhanced Radioiodine Uptake in Radioiodine-refractory Thyroid Cancer: A Case Report
1个月前
已完结
Clinical observation of Shuanghuang Shengbai Granule (双黄升白颗粒) on prevention and treatment of myelosuppression caused by chemotherapy in cancer patients
3个月前
已完结
BRAFV600E and KRAS mutation in thyroid lesions: a study on Giemsa-stained fine needle aspiration archival smears
4个月前
已完结
BRAF/MEK inhibitors for redifferentiation in patients with radioiodine refractory thyroid cancer: A systematic review and Meta-Analysis
4个月前
已完结
Do the ‘missing millions’ of COPD patients want to be found?
5个月前
已完结
皖公网安备34019202002308
